<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="372170">
  <stage>Registered</stage>
  <submitdate>15/01/2017</submitdate>
  <approvaldate>18/01/2017</approvaldate>
  <actrnumber>ACTRN12617000101381</actrnumber>
  <trial_identification>
    <studytitle>Use of Surgicel in Parotid Surgery</studytitle>
    <scientifictitle>Does the use of Surgicel after parotidectomy in adults increases the incidence of post-operative sialocele formation</scientifictitle>
    <utrn> U1111-1191-7117</utrn>
    <trialacronym>USiPS</trialacronym>
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Sialocele</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Surgicel is used after parotidectomy in the wound bed to aid in haemostasis and to protect the facial nerve.  Surgicel Original Haemostat (Ethicon) 0.5x2inch will be placed in the wound bed after parotidectomy by the treating surgeon prior to closing.</interventions>
    <comparator>No material/device will be placed in the wound bed at the time of surgery.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Surgery</interventioncode>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Sialocele formation which will be clinically diagnosed at the one week follow up outpatient appointment and confirmed and quantified on ultrasound</outcome>
      <timepoint>One week post surgery.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Drain output will be measured every 24hrs by direct observation of the drain bag by surgical staff caring for the patient and documented in the medical records.</outcome>
      <timepoint>Every 24 hours until drain removed</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Length of hospital stay as determined by days in hospital since operation to discharge</outcome>
      <timepoint>Days in hospital from operation date to discharge date</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Facial nerve palsy graded on the House-Brackmann scale from 1 to 5</outcome>
      <timepoint>Measured 2hrs, 24hrs and one week after operation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>All patients undergoing a parotidectomy</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>90</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Other procedures during the parotidectomy (neck dissection) and radical parotidectomies.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Central randomisation by computer</concealment>
    <sequence>Permuted block randomisation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>False</masking2>
    <masking3>False</masking3>
    <masking4>False</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>6/02/2017</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>230</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>QLD</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Gold Coast University Hospital</primarysponsorname>
    <primarysponsoraddress>1 Hospital Boulevard, off Parklands Drive, Southport, Gold Coast, Queensland, Australia. 4215</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Gold Coast University Hospital</fundingname>
      <fundingaddress>1 Hospital Boulevard, off Parklands Drive, Southport, Gold Coast, Queensland, Australia. 4215</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Ipswich Hospital</fundingname>
      <fundingaddress>Chelmsford Avenue
Ipswich Queensland 4305</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Toowoomba Hospital</fundingname>
      <fundingaddress>Toowoomba Hospital
Pechey Street
Toowoomba Qld 4350</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Royal Brisbane Women's Hospital</fundingname>
      <fundingaddress>Butterfield Street
HERSTON  QLD  4029
AUSTRALIA</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Townsville Hospital</fundingname>
      <fundingaddress>100 Angus Smith Drive, Douglas QLD 4814</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Sunshine Coast University Hospital</fundingname>
      <fundingaddress>Sunshine Coast University Hospital
Project Office, K1 Building
16 Innovation Parkway
Birtinya Qld 4575</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of this study is to evaluate the effect of Surgicel use in parotid surgery on the incidence of post-operative sialocele formation.

Who is it for?
You may be eligible to join this study if you are aged 18-90 years and are scheduled to undergo a parotidectomy.

Study details
Patients will be randomized (allocated by chance) to use of Surgicel (a type of oxidised regenerated cellulose) or no use of Surgicel in the control arm. Surgicel is used after parotidectomy in the wound bed to aid in haemostasis and to protect the facial nerve. Surgicel Original Haemostat (Ethicon) 0.5x2inch will be placed in the wound bed after parotidectomy by the treating surgeon prior to closing. The primary outcome will be formation of a sialocele post-operatively, quantified on ultrasound if a sialocele is clinically detected at the one week follow up. Secondary outcomes examined will include drain output, length of hospital stay and other post-operative complications.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Gold Coast University Hospital Ethics Committee</ethicname>
      <ethicaddress>Research Directorate
Level 2, Pathology and Education Building
1 Hospital Boulevard
Southport, QLD, 4215</ethicaddress>
      <ethicapprovaldate>13/10/2016</ethicapprovaldate>
      <hrec>HREC/16/QGC/272</hrec>
      <ethicsubmitdate>10/10/2016</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Danielle Wiltshire</name>
      <address>Ipswich Hospital
PO Box 73
IPSWICH QLD 4305</address>
      <phone>+61 7 3810 1111</phone>
      <fax />
      <email>danielle.wiltshire@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Danielle Wiltshire</name>
      <address>Ipswich Hospital
PO Box 73
IPSWICH QLD 4305</address>
      <phone>+61 7 3810 1111</phone>
      <fax />
      <email>danielle.wiltshire@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Danielle Wiltshire</name>
      <address>Ipswich Hospital
PO Box 73
IPSWICH QLD 4305</address>
      <phone>+61 7 3810 1111</phone>
      <fax />
      <email>danielle.wiltshire@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Danielle Wiltshire</name>
      <address>Dr Danielle Wiltshire
Ipswich Hospital
PO Box 73
IPSWICH QLD 4305</address>
      <phone />
      <fax />
      <email>danielle.wiltshire@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>